Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications hifmech study group plasminogen activator inhibitor 1 675 4g5g genotype influences risk
Case Studies Learn more about our experience and expertise. Read our case studies. …
… cancer susceptibility genes are known to increase the risk of inheriting breast cancer. Genetic testing enables … for those considering or undergoing testing. In a recent study co-authored by RTI Health Solutions researchers and … Results From a US Retrospective Medical Records Review Study . Elias Obeid, Rohan C. Parikh , Elizabeth Esterberg , …
… collection through to transfusion. They found that the risk of adverse events was small for both methods, but the … it is acknowledged that PRT is associated with reduced risk of contamination because of emerging viral pathogens and … PCs, and reduce health care costs.” Learn more about the study here . Related Services Health Economics Staff …
… of CV illnesses. Recent projects have included: Benefit-risk preference studies Cohort and case-control studies … pediatric investigational plans Epidemiology sections of risk management plans Literature reviews Measurement of …
… Nuria Saigi-Morgui Pharmacoepidemiology and Risk Management Barcelona, Spain PhD, Pharmacogenetics … psychotropic treatments through an observational clinical study that involved coordination of a multidisciplinary team, … She also acquired experience in designing and re-adapting study protocol according to guidelines and ethics committee …
… data set into as many exposure groups as you want to study, second, censoring those clones when they deviate from … like HIV, cardiovascular, and cancer research. In this study we explored an alternative to cloning, based on …
… in the field of pharmacoepidemiology. His experience and publications span a wide range of substantive areas, … clinical and public health audiences about observational study design, large database utilization, and propensity … and as the Chair of the Vaccine Special Interest Group. …
… differences between the population in the pivotal clinical study (e.g., stage of disease) and the population that … of the PRO instrument should be clearly specified in a study protocol and statistical analysis plan and should … will vary based on whether the instrument supports a study’s primary endpoint, inclusion criteria, or a safety …
… arising from treatment of respiratory illnesses. Benefit-risk preference studies Consulting on drug development and … Reimbursement dossiers and value communication strategies Risk management programs including development, …
… of GI illnesses. Recent projects have included: Benefit-risk preference studies Cohort and case-control studies … research Reimbursement and value communication strategies Risk management programs including development, …